Last reviewed · How we verify
E. Coli Appendicitis
Approved treatments
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- E. Coli Appendicitis patent landscape — cliff calendar, originator estates, attackable patents
- E. Coli Appendicitis treatment landscape brief
- E. Coli Appendicitis treatment updates RSS
Frequently asked questions about E. Coli Appendicitis
What drugs treat E. Coli Appendicitis?
Tracked treatments include Pipracil, Zosyn.
What is the treatment for E. Coli Appendicitis?
Standard treatment for E. Coli Appendicitis includes Pipracil, Zosyn. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: E. Coli Appendicitis patent cliff · E. Coli Appendicitis CI report
- Treatment: Pipracil
- Treatment: Zosyn · Merck Sharp & Dohme B.V.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing